research technology and solutions
hematology micm diagnostic system
the icm diagnostic system includes morphology, immunology, cytogenetics, and molecular biology. diagnostic typing of leukemia through different layers provides a basis for later clinical treatment. aussie beacon can provide comprehensive diagnostic protocols for hematologic micp, including cell morphology, flow cytometry, karyotyping, and fluorescence in situ hybridization for chromosomal abnormalities.found blood cell composition and abnormal morphology; understand the state of bone marrow hematopoietic function; provide a basis for diagnosis of blood diseases or provide important clues.
achieve acute leukemia typing, lymphoma, mds/mpn/aa, metastatic cancer, mrd detection, immune function testing.
the chromosome-specific high-resolution banding technique was used to determine the specific chromosomal abnormalities of leukemia.
fluorescence in situ hybridization analysis was used to detect chromosome and gene abnormalities from the perspective of genetics; early recurrence after transplantation, diagnosis of blood diseases, prognosis, efficacy detection and micro-residue detection were identified.
shenzhen headquarters
address: building a17, life science industrial park, kwai chung street, dapeng new district, shenzhenshanghai headquarters
address: building 21, phase 4, shanghai international medical parkscan on us
©尊龙凯时 copyright shenzhen tissue bank precision medicine co., ltd. 尊龙凯时 copyright